PINK1 and cancer: Recent evidence highlights critical interactions between the PI3K/AKT/mTOR pathway and PINK1, suggesting their crosstalk significantly impacts cancer progression, therapeutic resistance, and metabolic plasticity, especially under stress conditions such as metastatic dissemination to the brain.